[ Price : $8.95]
CBER director Peter Marks says he expects 2024 to be a big year for gene therapy approvals as several Center initiatives take hold...[ Price : $8.95]
Four stakeholders update comments on the latest version of an FDA draft guidance on topical ophthalmic products.[ Price : $8.95]
FDA warns Amman, Jordan-based Amman Pharmaceutical Industries about CGMP violations in its production of drugs as a contract manuf...[ Price : $8.95]
FDA fails to locate the UK-based manufacturer of filthy eye drops, LightEyez, accused of manufacturing and distributing unapproved...[ Price : $8.95]
FDA warns Mamaroneck, NY-based Delsam Pharma, and Lakewood, NJ-based EzriCare about distributing adulterated and misbranded ophtha...[ Price : $8.95]
FDA denies a Boehringer Ingelheim petition asking it to change its interpretation of strength for parenteral solutions under the B...[ Price : $8.95]
FDA posts a final guidance entitled Reporting Amount of Listed Drugs and Biological Products Technical Conformance Guide.[ Price : $8.95]
FDA India director Sarah McMullen says the agency is working to increase drug inspections in India and station additional investig...